
Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

